Icon
+91 94997 68112
Login Register

TEPADINA AND SODIUM CHLORIDE - (200MG, 400MG)

THIOTEPA None
200MG, 400MG
Less Than $1000 mn
None None
None None
None None
TEPADINA (thiotepa) is an alkylating drug indicated:  To reduce the risk of graft rejection when used in conjunction with high-dose busulfan and cyclophosphamide as a preparative regimen for allogeneic hematopoietic progenitor (stem) cell transplantation (HSCT) for pediatric patients with class 3 beta-thalassemia.  For treatment of adenocarcinoma of the breast or ovary.  For controlling intracavitary effusions secondary to diffuse or localized neoplastic diseases of various serosal cavities.  For treatment of superficial papillary carcinoma of the urinary bladder.
Yes
TEPADINA AND SODIUM CHLORIDE Patent 1
*** *********

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.